P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: van de Donk, N. W. C. J, Popat, R, Hulin, C, Jagannath, S, Oriol, A, Richardson, P. G, Facon, T, Weisel, K, Larsen, J. T, Minnema, M, Abdallah, A, Badros, A. Z, Knop, S, Stadtmauer, E. A, Chen, M, Nguyen, T. V, Amin, A, Peluso, T, Lonial, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Poster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009805/
http://dx.doi.org/10.1097/01.HS9.0000829600.37424.88
_version_ 1784687343418998784
author van de Donk, N. W. C. J
Popat, R
Hulin, C
Jagannath, S
Oriol, A
Richardson, P. G
Facon, T
Weisel, K
Larsen, J. T
Minnema, M
Abdallah, A
Badros, A. Z
Knop, S
Stadtmauer, E. A
Chen, M
Nguyen, T. V
Amin, A
Peluso, T
Lonial, S
author_facet van de Donk, N. W. C. J
Popat, R
Hulin, C
Jagannath, S
Oriol, A
Richardson, P. G
Facon, T
Weisel, K
Larsen, J. T
Minnema, M
Abdallah, A
Badros, A. Z
Knop, S
Stadtmauer, E. A
Chen, M
Nguyen, T. V
Amin, A
Peluso, T
Lonial, S
author_sort van de Donk, N. W. C. J
collection PubMed
description
format Online
Article
Text
id pubmed-9009805
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-90098052022-04-18 P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA van de Donk, N. W. C. J Popat, R Hulin, C Jagannath, S Oriol, A Richardson, P. G Facon, T Weisel, K Larsen, J. T Minnema, M Abdallah, A Badros, A. Z Knop, S Stadtmauer, E. A Chen, M Nguyen, T. V Amin, A Peluso, T Lonial, S Hemasphere Poster Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9009805/ http://dx.doi.org/10.1097/01.HS9.0000829600.37424.88 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Poster
van de Donk, N. W. C. J
Popat, R
Hulin, C
Jagannath, S
Oriol, A
Richardson, P. G
Facon, T
Weisel, K
Larsen, J. T
Minnema, M
Abdallah, A
Badros, A. Z
Knop, S
Stadtmauer, E. A
Chen, M
Nguyen, T. V
Amin, A
Peluso, T
Lonial, S
P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_full P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_fullStr P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_full_unstemmed P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_short P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_sort p07: results from the cc-220-mm-001 dose-expansion phase of iberdomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009805/
http://dx.doi.org/10.1097/01.HS9.0000829600.37424.88
work_keys_str_mv AT vandedonknwcj p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT popatr p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT hulinc p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT jagannaths p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT oriola p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT richardsonpg p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT facont p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT weiselk p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT larsenjt p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT minnemam p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT abdallaha p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT badrosaz p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT knops p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT stadtmauerea p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT chenm p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT nguyentv p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT amina p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT pelusot p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma
AT lonials p07resultsfromthecc220mm001doseexpansionphaseofiberdomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma

Ejemplares similares